Literature DB >> 11753962

The impact of patient and professional diagnostic delays on survival in pharyngeal cancer.

P Koivunen1, N Rantala, K Hyrynkangas, K Jokinen, O P Alho.   

Abstract

BACKGROUND: Cancers of the head and neck still are detected mostly at an advanced stage, especially pharyngeal cancers.
METHODS: To study the impact of patient and professional delay on survival, the authors collected the data from 84 patients with pharyngeal cancer. In addition to clinical data from the tertiary care center, the authors evaluated the data from the first medical visit in primary care before the diagnosis of malignancy had been made.
RESULTS: The patients who had a patient delay of 2 months or more had a significantly higher relative hazard of death (HR; HR, 2.5; 95% confidence interval (CI), 1.39-4.38) compared with the patients with less than 2 months of patient delay. This risk was significant among the patients with oropharyngeal (P = 0.008) and nasopharyngeal cancer (P = 0.03), but not in those with hypopharyngeal cancer (P = 0.56). In contrast, there was no relation between professional diagnostic delay and prognosis. Advanced stage (International Union Against Cancer [UICC] TNM; Stage IV vs. Stage I-III; HR, 3.19; CI, 1.61-6.35) and age (> or = 65 vs. < 65 years; HR, 2.47; CI, 1.32-4.62) also were associated with an impaired prognosis.
CONCLUSIONS: Shortening of patient delay would substantially improve survival in pharyngeal cancer, but this goal seems difficult to attain because symptoms emerge late in pharyngeal cancer, and no specific symptoms or patient characteristics were related to a long patient delay. Professional delay does not have an impact on survival in pharyngeal cancer. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11753962     DOI: 10.1002/1097-0142(20011201)92:11<2885::aid-cncr10119>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  [Delayed diagnosis of oral squamous cell neoplasms at different sites].

Authors:  T Xu; D C Wang; X F Shan; Z G Cai
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

2.  A multidisciplinary audit of head and neck referrals: considerations for patients' timelines and outcomes.

Authors:  Natasha Choudhury; Yasmin Hassen; Juveria Siddiqui; Adam Falzon; Khalid Ghufoor
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-28       Impact factor: 2.503

3.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

4.  Head and neck cancer in primary care: presenting symptoms and the effect of delayed diagnosis of cancer cases.

Authors:  Olli-Pekka Alho; Heikki Teppo; Pekka Mäntyselkä; Saara Kantola
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

5.  Autoantibody approach for serum-based detection of head and neck cancer.

Authors:  Ho-Sheng Lin; Harvinder S Talwar; Adi L Tarca; Alexei Ionan; Madhumita Chatterjee; Bin Ye; Jerzy Wojciechowski; Saroj Mohapatra; Marc D Basson; George H Yoo; Brian Peshek; Fulvio Lonardo; Chuan-Ju G Pan; Adam J Folbe; Sorin Draghici; Judith Abrams; Michael A Tainsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

6.  [Family practice and diagnosis of cancer].

Authors:  A Ruiz-Torrejón; M Ramos-Monserrat; J Llobera-Cánaves
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

7.  Delay in diagnosis of patients with head-and-neck cancer in Canada: impact of patient and provider delay.

Authors:  S Kassirian; A Dzioba; S Hamel; K Patel; A Sahovaler; D A Palma; N Read; V Venkatesan; A C Nichols; J Yoo; K Fung; A Mendez; S D MacNeil
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

8.  Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.

Authors:  Yuxuan Wang; Simeon Springer; Carolyn L Mulvey; Natalie Silliman; Joy Schaefer; Mark Sausen; Nathan James; Eleni M Rettig; Theresa Guo; Curtis R Pickering; Justin A Bishop; Christine H Chung; Joseph A Califano; David W Eisele; Carole Fakhry; Christine G Gourin; Patrick K Ha; Hyunseok Kang; Ana Kiess; Wayne M Koch; Jeffrey N Myers; Harry Quon; Jeremy D Richmon; David Sidransky; Ralph P Tufano; William H Westra; Chetan Bettegowda; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Nishant Agrawal
Journal:  Sci Transl Med       Date:  2015-06-24       Impact factor: 17.956

9.  Childhood cancer in developing society: A roadmap of health care.

Authors:  P M Ramesh; R K Marwaha; T S Anish
Journal:  Indian J Med Paediatr Oncol       Date:  2011-01

10.  Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.

Authors:  Maarten A Wildeman; Renske Fles; Camelia Herdini; Rai S Indrasari; Andrew D Vincent; Maesadji Tjokronagoro; Sharon Stoker; Johan Kurnianda; Baris Karakullukcu; Kartika W Taroeno-Hariadi; Olga Hamming-Vrieze; Jaap M Middeldorp; Bambang Hariwiyanto; Sofia M Haryana; I Bing Tan
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.